Human medicines European public assessment report (EPAR): Ryzneuta, efbemalenograstim alfa, Date of authorisation: 21/03/2024, Revision: 4, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 1 April 2026 - 16:55

Human medicines European public assessment report (EPAR): Ryzneuta, efbemalenograstim alfa, Date of authorisation: 21/03/2024, Revision: 4, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ryzneuta

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters